Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ravi Jasuja
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Function Promoting Therapies, LLC (DBA Tesvgen, LLC)
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This grant supports an interdisciplinary research network to foster translational research in function promoting therapies (FPTs) – pharmacologic, physical, nutritional, technological and behavioral interventions that reduce the burden of disabling functional limitations in older adults. Dr. Jasuja is the co-founder of Function Promoting Therapies (FPT), LLC (DBA Tesvgen, LLC), a biopharmaceutical company whose aim is to develop innovative solutions that enhance precision and accuracy in clinical decision making and facilitate personalized therapeutic choices in reproductive health. FPT, LLC currently has two pending patents: an algorithm to calculate free testosterone concentrations and the application of testosterone plus DFMO as a selective prostate sparing anabolic therapy. This grant supports many research collaborations and the results of the various projects could be of interest to the company because the company and the research are both focused on developing function promoting therapies. Given the magnitude of Dr. Jasuja’s financial interest and the close connection between the company's interests and the research, the Partners Committee on Outside Activities (COA) review panel determined that the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
Boston OAIC: A Translational Approach to Function Promoting Therapies
Narrative The Boston Older Americans Independence Center (Boston OAIC) has transcended the departmental, institutional, and disciplinary boundaries to forge an interdisciplinary research network to foster translational research in function promoting therapies (FPTs) ? pharmacologic, physical, nutritional, technological and behavioral interventions that reduce the burden of disabling functional limitations in older adults. The Boston OAIC will integrate 19 NIH-funded studies, 3 Research Education Core projects, 3 pilot projects, and 3 developmental projects into an interdisciplinary program that is supported by a Leadership and Administrative Core, a Research Education Core (REC), a Pilot and Exploratory Studies Core (PESC), and 3 resource cores (Function Assessment Core, Preclinical Discovery Core, Biostatistical and Data Analysis Core). Unique strengths of OAIC include its focus on FPTs, emphasis on translation and commercialization, access to a large pool of talented young investigators, its extension across the entire spectrum of translational research, the outstanding productivity of its members, strong institutional support, and its success in developing intellectual property and companies, and supporting some of the most important randomized trials of FPTs.
Filed on July 13, 2016.
Tell us what you know about Ravi Jasuja's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Ravi Jasuja”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Ravi Jasuja | Brigham and Women's Hospital | Conflict of Interest | Function Promoting Therapies, LLC (DBA Tesvgen, LLC) | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.